Virtus ETF Advisers LLC Adagio Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.97 - $4.83 $840 - $1,366	283 Added 0.72%	39,564 $124,000
Q2 2022 Aug 12, 2022	BUY	$2.54 - $4.52 $45,532 - $81,025	17,926 Added 83.94%	39,281 $129,000
Q1 2022 May 16, 2022	SELL	$3.81 - $10.77 $4,838 - $13,677	-1,270 Reduced 5.61%	21,355 $97,000
Q4 2021 Feb 14, 2022	BUY	$6.35 - $47.04 $143,668 - $1.06 Million	22,625 New	22,625 $164,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.